Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AA PHARMA METRONIDAZOLE TABLET 250 MG - HSA Drug Approval Details

Approvals/HSA/AA PHARMA METRONIDAZOLE TABLET 250 MG

Approved

THERAPEUTIC

AA PHARMA METRONIDAZOLE TABLET 250 MG

APOTEX INC (CANADA)🇸🇬 Health Sciences Authority

Approval Date: Aug 13, 1989
Approval ID: 6c2a37fb10a85879
Company: APOTEX INC (CANADA)
Type: Therapeutic

Approval Details

Approval Id: 6c2a37fb10a85879
Drug Name: AA PHARMA METRONIDAZOLE TABLET 250 MG
Product Name: AA PHARMA METRONIDAZOLE TABLET 250 MG
Approval Number: SIN03741P
Approval Date: 1989-08-13
Registrant: PHARMAFORTE SINGAPORE PTE LTD
Licence Holder: PHARMAFORTE SINGAPORE PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: J01XD01
Atc Item Name: metronidazole
Pharma Manufacturer Name: PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path: /organization/pharmaforte-singapore-pte-ltd

Active Ingredients

METRONIDAZOLE

250 mg

METRONIDAZOLE

250 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 13, 1989

Approval ID

6c2a37fb10a85879

Type

Therapeutic

Back to HSA Approvals